Macquarie Stem Cells has provided this information to educate the public based on peer reviewed, published scientific and medical documents. We don’t aim to encourage consumers to seek out such treatments prior to an assessment by a health professional to determine your suitability for treatment. This is obtained directly from Osteoarthritis Research Society International.
Published Online: Osteoarthritis Research Society International – 2017
The new guidelines recommend a set of non-pharmacological core treatments as appropriate for all individuals, these are listed below.
Biological Treatments are showing significant growth. Based on the current 2017 literature review by Dr. Pak, Biological Treatments “have a great clinical potential to treat various orthopedic disorders as seen in human studies. This may be worthwhile to try in individuals for whom medical treatment has failed and for whom surgical options are not available”.
(Pak J. et al, 2017.) (2)
If you would like to learn more about these biological treatment options, please click here.
1. REF: Osteoarthritis Research Society International. (2017). OARSI Guidelines. [online] Available at: https://www.oarsi.org/education/oarsi-guidelines [Accessed 22 Sep. 2017].
2. REF: Pak, J., Lee, J., Park, K., Park, M., Kang, L. and Lee, S. (2017). Current use of autologous adipose tissue-derived stromal vascular fraction cells for orthopedic applications. Journal of Biomedical Science, 24(1).
Tags: Macquarie Stem Cells, Dr. Bright, Osteoarthritis Treatment, Dr. Ralph Bright, biological treatments for arthritis, OARSI guidelines, arthritis guidelines, new treatment for arthritis
Remember, any surgical or invasive procedure carries risks. Before proceeding, you should seek a second opinion from an appropriately qualified health practitioner.